This new tool, known as minimal, versatile genetic perturbation technology (mvGPT), combines the powers of gene editing, ...
For the last 10 years, the only effective treatment for hypophosphatasia (HPP) has been an enzyme replacement therapy that ...
Genetic medicines could treat certain diseases, however, the current delivery systems available—viral vectors and lipid nanoparticles (LNPs)—pose unique challenges for gene therapy applications. For ...
For the last 10 years, the only effective treatment for hypophosphatasia (HPP) has been an enzyme replacement therapy that must be delivered by injection three-to-six times each week.
BENGALURU: Bengaluru-based Narayana Nethralaya is developing gene therapy solutions that could drastically reduce the cost of ...
The majority are in the very early preclinical stage of development, but applications for regulatory approval have been ...
A new gene editing treatment has been approved for use in the NHS, which will help treat sickle cell disease patients ...